The majority of those were in the TP53 locus; however, genetic alterations were also found in the CDKN2A, RB1, and BRCA2, as well as the STK11 locus (also known as LKB1), which is a well-known tumor suppressor in lung cancer [44]. Here, CDKN2A is linked to lung carcinoma.